TickerFactsScreenerDevelopers

Anbio Biotechnology (NNNN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: $4.45M2023: $898.4K2024: $2.08M2025: -$6.74M-$6.74M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.74M-423.9%
2024$2.08M+131.6%
2023$898.4K-79.8%
2022$4.45M—